Auxilium On a Roll ...
Health Care: Drugs
Endo Pharmaceutical Holdings Inc. (ENDP: NASDAQ)
$30.87 -0.45 | -1.44%
06/04/12 - 04:00 PM ET
Ratio Comparisons
| Company | Industry | S&P 500 | |
| Valuation Ratios | |||
|---|---|---|---|
| P/E Ratio (TTM) | 92.10 | 28.50 | 17.70 |
| P/E High - Last 5 Yrs | 28.70 | 189.00 | 67.70 |
| P/E Low - Last 5 Yrs | 6.50 | 18.60 | 12.50 |
| Beta | 0.67 | 0.62 | 0.98 |
| Price to Sales (TTM) | 1.28 | 4.29 | 1.42 |
| Price to Book (MRQ) | 1.94 | 4.39 | 2.41 |
| Price to Tangible Book (MRQ) | -1.19 | 14.20 | 5.08 |
| Price to Cash Flow (TTM) | 10.90 | 19.50 | 9.80 |
| Price to Free Cash Flow (TTM) | -1.90 | -327.00 | 17.40 |
| Dividends | |||
| Dividend Yield (%) | 0.00 | 0.90 | 2.10 |
| Dividend Yield - 5 Yr Avg (%) | n.a. | 0.80 | 2.20 |
| Dividend 5 Yr Growth Rate (%) | n.a. | 42.32 | -0.76 |
| Payout Ratio (TTM) | 0.00 | 51.00 | 30.00 |
| Sales (MRQ) vs Qtr 1 Yr Ago (%) | 23.30 | 15.60 | 11.80 |
| Sales (TTM) vs TTM 1 Yr Ago (%) | 59.10 | 9.00 | 9.20 |
| Growth Rates (%) | |||
| Sales - 5 Yr Growth Rate (%) | 21.67 | 6.32 | 1.79 |
| EPS (MRQ) vs Qtr 1 Yr Ago (%) | -100.00 | -2.50 | 17.50 |
| EPS (TTM) vs TTM 1 Yr Ago (%) | -100.00 | -2.50 | 17.50 |
| EPS - 5 Yr Growth Rate (%) | 7.48 | 24.63 | -1.66 |
| Capital Spending - 5 Yr Growth Rate (%) | 150.83 | -6.43 | -1.17 |
| Financial Strength | |||
| Quick Ratio (MRQ) | 0.90 | 1.30 | 1.10 |
| Current Ratio (MRQ) | 1.40 | 1.80 | 1.60 |
| LT Debt to Equity (MRQ) | 1.69 | 0.29 | 0.82 |
| Total Debt to Equity (MRQ) | 1.75 | 0.37 | 0.96 |
| Interest Coverage (TTM) | 1.50 | 9.20 | 5.50 |
| Profitability Ratios (%) | |||
| Gross Margin (TTM) | 68.30 | 75.60 | 46.90 |
| Gross Margin - 5 Yr Avg | 77.40 | 75.30 | 47.70 |
| EBITD Margin (TTM) | 28.10 | 29.40 | 18.90 |
| EBITD - 5 Yr Avg | 33.92 | 0.00 | 0.00 |
| Pre-Tax Margin (TTM) | 4.80 | 18.00 | 12.10 |
| Pre-Tax Margin - 5 Yr Avg | 22.90 | 11.80 | 10.30 |
| Management Effectiveness (%) | |||
| Net Profit Margin (TTM) | 0.02 | 0.14 | 0.09 |
| Net Profit Margin - 5 Yr Avg | 14.60 | 8.60 | 7.00 |
| Return on Assets (TTM) | 0.60 | 7.30 | 3.10 |
| Return on Assets - 5 Yr Avg | 6.90 | 4.60 | 2.50 |
| Return on Investment (TTM) | 0.90 | 10.40 | 7.90 |
| Return on Investment - 5 Yr Avg | 9.60 | 6.50 | 6.50 |
| Efficiency | |||
| Revenue/Employee (TTM) | 626,528.00 | 404,888.00 | 449,376.00 |
| Net Income/Employee (TTM) | 9,742.00 | 57,122.00 | 39,003.00 |
| Receivable Turnover (TTM) | 4.60 | 4.70 | 7.60 |
| Inventory Turnover (TTM) | 3.70 | 1.70 | 8.30 |
| Asset Turnover (TTM) | 0.50 | 0.60 | 0.40 |
Portfolios with ENDP
- Portfolio NameUser Type
- ContributorStocks Rising On Unusual Vo...
- ProLee Ainslie - Maverick Capital
- ProD.E. Shaw
- ContributorTechnical Setups for the We...
- ContributorStocks Rising On Unusual Vo...
- ContributorBreakout Stocks Of The Week...
- ProChuck Royce - Royce & Assoc...
- ProJohn Hussman
- ContributorTechnical Setups for the We...
- ProZebra Capital
Latest ENDP Headlines from TheStreet
- 7 Stocks Surging on Big Volume 05.29.12 | 01:05 pm
- Downgrades Roundup: SPX, Avon, Shutterfly 05.07.12 | 07:05 am
- Endo Pharmaceutical Holdings Inc. Stock Downgraded (ENDP) 05.03.12 | 05:05 am
- Endo Pharmaceuticals Holdings' CEO Discusses Q1 2012 Results - Earnings Call Transcript 05.01.12 | 03:05 pm
- Endo Pharmaceuticals' CEO Discusses Q4 2011 Results - Earnings Call Transcript 02.24.12 | 12:02 pm
- BioSante: A Penny Stock Still Overvalued 02.16.12 | 07:02 am
- UBS: 6 Specialty Pharma Picks to Watch 01.21.12 | 07:01 am
- Endo Pharmaceutical Holdings Inc. (ENDP): Today's Featured Health Care Winner 12.12.11 | 04:12 pm
- 7 Stocks Rising on Unusual Volume 12.12.11 | 12:12 pm
- Endo Pharmaceuticals At 2011 Credit Suisse Annual Health Care Conference Call Transcript 11.11.11 | 02:11 pm
Press Releases for ENDP
- Endo Announces Resolution Of Patent Litigation With Watson Pharmaceuticals Related To Lidoderm® - PR Newswire 05.29.12 | 07:05 am
- Endo Health Solutions Inc. To Present At Jefferies 2012 Global Healthcare Conference - PR Newswire 05.25.12 | 01:05 pm
- Endo Health Solutions Inc. To Present At The Goldman Sachs 33rd Annual Global Healthcare Conference - PR Newswire 05.25.12 | 01:05 pm
- Endo Health Solutions Inc. Announced As New Name For Endo Pharmaceuticals Holdings Inc. - PR Newswire 05.23.12 | 02:05 pm
- Endo Pharmaceuticals To Announce First Quarter 2012 Financial Results On May 1, 2012 - PR Newswire 04.17.12 | 09:04 am
- Qualitest Pharmaceuticals Receives FDA Approval For Levetiracetam Oral Solution, 100 Mg/mL - PR Newswire 04.12.12 | 04:04 pm
- Endo Announces Departure Of American Medical Systems President - PR Newswire 03.29.12 | 01:03 pm
- Endo Acquires Johnson Matthey's Oxymorphone Patent - PR Newswire 03.22.12 | 08:03 am
- BioDelivery Sciences Provides Business Review And Update In Conjunction With Filing Of Its Annual Report - PR Newswire 03.19.12 | 04:03 pm
- Endo Files Amended Citizen Petition Seeking Public FDA Resolution Of Several Safety And Efficacy Issues Prior To Approval Of A Generic Formulation Of LIDODERM® - PR Newswire 03.13.12 | 08:03 am
Partner Headlines for ENDP
- UNVEILED: Analyst Share Price Targets Wednesday - Wall St. Cheat Sheet 05.30.12 | 04:05 am
- Healthcare Biz Recap: HGSI Shareholder Sues, Endo Health Kisses Watson Pharma - Wall St. Cheat Sheet 05.29.12 | 11:05 am
- Auxilium-Glaxo to Drive Testim Sales - Analyst Blog - Zacks 05.22.12 | 10:05 am
- UPDATE: Citigroup Rates Endo Pharmaceuticals as Buy, $48 TP - Benzinga 03.26.12 | 12:03 pm
- BioDelivery Sciences Provides Business Review - Benzinga 03.19.12 | 04:03 pm
- VIX - Options Volatility Sonar: Friday Recap - Seeking Alpha 03.09.12 | 04:03 pm
- Earnings Beat at Endo Pharma - Analyst Blog - Zacks 02.28.12 | 09:02 am
- Stocks To Watch This Week - Seeking Alpha 01.10.12 | 08:01 am
- Billionaire David Shaw's Favorite Stock Picks - Seeking Alpha 12.15.11 | 09:12 am
- Nupathe's Zelrix Going Down A Path With Multiple Headwinds - Seeking Alpha 12.09.11 | 09:12 am
